Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Conduit Pharmaceuticals Inc. - Common Stock
(NQ:
CDT
)
0.0747
+0.0091 (+13.87%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,962,541
Open
0.0619
Bid (Size)
0.0680 (65)
Ask (Size)
0.0709 (5)
Prev. Close
0.0656
Today's Range
0.0619 - 0.0758
52wk Range
0.0619 - 5.440
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 12, 2024
Via
Benzinga
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 12, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Performance
YTD
-98.41%
-98.41%
1 Month
-28.17%
-28.17%
3 Month
-40.86%
-40.86%
6 Month
-94.85%
-94.85%
1 Year
-98.52%
-98.52%
More News
Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?
August 14, 2024
Via
InvestorPlace
What's Going On With Conduit Pharmaceuticals Shares Today?
November 21, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 21, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
November 19, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
November 11, 2024
Via
Benzinga
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
November 04, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
November 01, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
October 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
October 11, 2024
Via
Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
October 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
September 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 14, 2024
Via
InvestorPlace
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
August 14, 2024
Via
Benzinga
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024
August 13, 2024
Via
InvestorPlace
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 12, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.